• In early May 2026, Jack Henry & Associates reported third-quarter fiscal 2026 results showing higher sales of US$636.25 million and increased net income of US$122.89 million, alongside updated full-year guidance calling for up to US$2.53 billion in revenue, operating margins near 25%, and earnings per share between US$6.78 and US$6.87.
• The company also continued to reshape its capital structure, completing repurchases of over 40% of its shares since 2002, while raising full-year deconversion revenue guidance to US$37 million after recording US$18.7 million in deconversion revenue in the third quarter.
• With Jack Henry lifting full-year earnings guidance, we’ll now examine how this updated outlook interacts with the existing investment narrative.

AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Jack Henry & Associates Investment Narrative Recap

To own Jack Henry & Associates, you need to believe in its role as a long-term technology partner to banks and credit unions, particularly as clients modernize core systems and payments. The latest results and higher full year guidance reinforce this narrative and support the near term catalyst around cloud and digital adoption, while the biggest risk remains pressure on its regional bank customer base from consolidation and competition.

The most relevant update here is the raised full year deconversion revenue guidance to US$37 million after Jack Henry booked US$18.7 million in deconversion revenue in the third quarter. Deconversion activity often accompanies client churn or consolidation, so while it adds to near term revenue, it also reminds investors that bank mergers and competitive shifts can reduce Jack Henry’s long term addressable base even as the business benefits from modernization demand today.

Yet behind the upgraded outlook, investors should be aware of how accelerating bank consolidation could...

Jack Henry & Associates' narrative projects $3.0 billion revenue and $575.6 million earnings by 2029. This requires 6.2% yearly revenue growth and about a $68.2 million earnings increase from $507.4 million today.

Uncover how Jack Henry & Associates' forecasts yield a $199.36 fair value, a 37% upside to its current price.

Exploring Other Perspectives

Three members of the Simply Wall St Community value Jack Henry & Associates between US$172.29 and US$199.36 per share, illustrating a wide span of expectations. Against that backdrop, the company’s higher full year earnings guidance and strong core wins put more focus on whether its largely regional U.S. client base can withstand consolidation and competitive pressure over time.

Explore 3 other fair value estimates on Jack Henry & Associates - why the stock might be worth just $172.29!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Jack Henry & Associates research is our analysis highlighting 5 key rewards that could impact your investment decision.
• Our free Jack Henry & Associates research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Jack Henry & Associates' overall financial health at a glance.

Want Some Alternatives?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Explore 27 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• Uncover the next big thing with 25 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.